Patient advocate Ella Balasa has been living with cystic fibrosis her whole life. She experienced a multidrug resistant infection in 2019 and is speaking about her personal experiences at the World AMR Congress reminding people about the need to improve the antibiotic development paradigm.
Biotech company is developing a product for a potential functional cure of the virus.
Due to increased RSV activity in the southeast United States, the CDC has issued an official Health Alert Network Health Advisory. The federal agency recommends clinicians prepare to implement recently FDA-approved prevention methods.
The Escherichia coli O157:H7 strain is linked to leafy greens–associated outbreaks over a multi-year period.
The company says its vaccine protects against the BA286 strain.
The formulation of Abacavir (ABC)/Dolutegravir (DTG)/Lamivudine (3TC) is a once-daily treatment for children living with HIV and meant to reduce pill burden.
In the latest Bench to Bedside column, 2 clinicians discuss the benefits of utilizing social media for learning.
Investigators found that while general hospitalizations decreased in 2020, hospitalizations due to alcohol-associated hepatitis increased by 16%.
From baby formula to ground beef to Trader Joe’s tamales, here are some recent foods to be aware of for recalls and warnings.
The European Medicines Agency (EMA) based its decision on preclinical data showing that the Omicron XBB.1.5-adapted monovalent COVID-19 vaccine generates an improved response against multiple XBB-related sublineages, including XBB15, XBB116, XBB23, and EG51.
Learn more about an investigational antibiotic; a new series on the RSV pipeline and recently approved products; a review of an older antibiotic for a specific STI treatment; and a patient advocate's experience with C diff.
A new study found a higher risk of CDI associated with clindamycin and lower risk associated with doxycycline and minocycline, also highlighting variation in CDI risk within and between classes of antibiotics.
The CDC reports the original COVID-19 monovalent and bivalent vaccines helped reduce emergency department or urgent care encounters for children aged 6 months to 5 years.
From a virus that had no treatment options, to one that may be prevented in two different modalities, clinicians are hoping to see a reduction in respiratory syncytial virus (RSV) incidence rates, starting this fall.
In preclinical studies, the antimicrobial, clovibactin, was shown to have susceptibility against a broad spectrum of pathogens and also worked against a specific bacteria in 2 animal studies.
If approved, the investigational vaccine would be available to people 18 years and older.
This is part of an occasional series with members of the Peggy Lillis Foundation. Here is an opportunity to hear about people’s experiences, lessons learned, and the new treatments that can lead to hope and not the hopelessness people have been living with during their ordeals.
Associated with excessive alcohol use, cirrhosis is one condition that can affect the pediatric population in the absence of alcohol.
This is the first in an occasional series with members of the Peggy Lillis Foundation. Here is an opportunity to hear about people’s experiences, lessons learned, and the new treatments that can lead to hope and not the hopelessness people have been living with during their ordeals.
With an increased incidence of this sexually transmitted infection, a review of an older antibiotic for treatment has shown some clinical benefits in other countries.
Here is a review of this specific case.
Clinicians offer insights on the individual respiratory viruses as well as addressing management of coinfections.
In this week's biggest stories, masks are seeing a small resurgence; expanding HCV screening for all persons with HIV; Pfizer's maternal vaccine gets FDA approved; and how a risk-based screening for multidrug-resistant gut microbes could improve accuracy and timeliness of empiric antibiotic treatment
With low vaccine utilization rates, finding educational resources to inform the public and increase attention to this preventative measure is needed to increase vaccinations.
Alyssa Dykstra is experiencing a drastic increase in paying for her medication for autoimmune arthritis. Insurers are utilizing a loophole provided by the federal government to allow them to disallow coupons, thus raising prescription costs for patients.
This is a challenging pathogen, requiring pharmacokinetic and pharmacodynamic considerations; the recent FDA approval of sulbactam-durlobactam offers new hope.
The federal agency says everyone should immediately stop using Dr. Berne’s MSM Drops 5% Solution and LightEyez MSM Eye Drops–Eye Repair due to bacterial contamination, fungal contamination, or both.
A risk-based screening for multidrug-resistant gut microbes could improve accuracy and timeliness of empiric antibiotic treatment of systemic infection.
Unique challenges can affect the success of the shift from pediatric to adult care settings.
Masking to reduce COVID-19 transmission risk is required at a few colleges and one major movie studio.
